Viewing Study NCT00955760


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 2:43 AM
Study NCT ID: NCT00955760
Status: COMPLETED
Last Update Posted: 2011-02-08
First Post: 2009-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate
Sponsor: Merz Pharmaceuticals GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module